Clinical Trial Update: Effectiveness of Rifabutin for Treatment of Helicobacter Pylori [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effectiveness of rifabutin for treatment of Helicobacter pylori infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis Due to Helicobacter Pylori
• Helicobacter Pylori Infection

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Helicobacter Infections, Resistance Bacterial | Phase 3 | Status: UNKNOWN